First Generic Versions of Coregâ„¢, FDA-Approved

Filed in archive FDA Approvals , Treatment on September 9, 2007

Coregâ„¢ - a product of GlaxoSmithKline - is a widely used FDA-approved medication for the treatment of high blood pressure, mild to severe chronic heart failure and left ventricular dysfunction following a heart attack.

Now, the FDA has recently approved the first generic versions of Coregâ„¢ (carvedilol) from the following drug companies:

• Actavis Elizabeth LLC


• Apotex Inc.


• Aurobindo Pharma Limited


• Caraco Pharmaceutical Laboratories Limited


• Dr. Reddy's Laboratories


• Glenmark Pharmaceuticals Limited


• lupin Limited


• Mylan Pharmaceuticals Inc.


• Ranbaxy Laboratories Ltd.


• Sandoz Inc.


• Taro Pharmaceutical Industries Ltd.


• TEVA Pharmaceuticals USA


• Watson Laboratories Inc.


• and Zydus Pharmaceuticals USA Inc.

Carvedilol tablets are available in four strengths (3.125 milligrams, 6.25 milligrams, 12.5 milligrams and 25 milligrams).

I have always been sceptical of it actually, thinking that though it is cheaper, it is less effective than that of the original branded version. But that's just me. What do you think of generic drugs?

Source: FDA News

[Photo Credit: australian-pharmacies.com]